Veeva Systems Inc.VEEV
NYSE • Healthcare
$156.25
P/E
28.10
PEG
1.13
FCF Yield
—
Rev Growth YoY
+16.0% YoY
Gross Margin
74.5%
Health Score
8/10
D/E Ratio
0.01
Confidence
MEDIUM
Business Snapshot
Veeva Systems provides cloud-based software solutions purpose-built for the global life sciences industry, with its Vault platform serving as the core revenue driver across content management, quality, and regulatory applications. The company operates in the medical healthcare information services sub-sector and holds a dominant position as the leading provider of compliant cloud infrastructure for pharmaceutical and biotech firms, benefiting from high switching costs and deep regulatory integration. With TTM revenue of $3.20B, Veeva is financially substantial, though its exact market cap is not available in the data. The defining competitive advantage is its deep specialisation in life sciences compliance, creating a regulatory moat that makes its platforms difficult for generalist competitors to replicate.
Financial Health
Gross margin stands at 74.5%, slightly down from 75.4% in the prior year, while net margin is a strong 28.4%, indicating efficient conversion of revenue into profit. The balance sheet is fortress-grade: debt-to-equity is negligible at 0.01x, and the current ratio of 4.89x provides ample short-term liquidity with no refinancing risk...
Risk Assessment
- VALUATION — P/E of 28.1x is 28% above the sector average of 22x, limiting the margin of safety.
- 52-WEEK POSITION — Current price of $156.25 sits well below the 52-week high of $310.50 and near the low of $148.05, reflecting a significant drawdown and potential downtrend risk.
- MARGIN CONTRACTION — Gross margin slipped to 74.5% from 75.4% in the prior year, signalling modest cost pressure or mix shift.
- TECHNICALS — RSI, MACD, and moving average data unavailable for this period; momentum cannot be independently confirmed.
- VALUATION DIVERGENCE — FMP DCF fair value of $120.53 implies a 29.6% premium to current price, suggesting the stock may be overextended relative to intrinsic value....